Concepedia

Daniel Magoon

DM

8

Publications

2.4K

Citations

8

H-Index

2011

Active since

Affiliations

Johns Hopkins University(Current)

Sidney Kimmel Comprehensive Cancer Center

Baylor College of Medicine

Johns Hopkins Medicine

Children's Cancer Center

Daniel Magoon is an author at Johns Hopkins University specializing in cell biology, medicine, and molecular diagnostics.

Top concepts

Publications per year

2011–2017

8

Publications

8

RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia

Johannes Zuber, Junwei Shi, Eric Wang et al. · Nature · 2011 · 1.9K citations

, , +7

A phase 1 dosing study of ruxolitinib in children with relapsed or refractory solid tumors, leukemias, or myeloproliferative neoplasms: A Children's Oncology Group phase 1 consortium study (ADVL1011)

Mignon L. Loh, Sarah K. Tasian, Karen R. Rabin et al. · Pediatric Blood & Cancer · 2015 · 126 citations

Dynamic Chemotherapy-Induced Upregulation of CXCR4 Expression: A Mechanism of Therapeutic Resistance in Pediatric AML

Edward Allan R. Sison, Emily McIntyre, Daniel Magoon et al. · Molecular Cancer Research · 2013 · 98 citations · Full text

A Phase I Study of Quizartinib Combined with Chemotherapy in Relapsed Childhood Leukemia: A Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study

Todd M. Cooper, Jeannette Cassar, Elena Eckroth et al. · Clinical Cancer Research · 2016 · 72 citations

A phase 1 study of the CXCR4 antagonist plerixafor in combination with high‐dose cytarabine and etoposide in children with relapsed or refractory acute leukemias or myelodysplastic syndrome: A Pediatric Oncology Experimental Therapeutics Investigators’ Consortium study (POE 10‐03)

Todd M. Cooper, Edward Allan R. Sison, Sharyn D. Baker et al. · Pediatric Blood & Cancer · 2017 · 71 citations · Full text

Rows per page

1–5 of 8